Source-linked briefing Health

Experimental Compound BA-101 May Reverse Glioblastoma Drug Resistance

Experimental Compound BA-101 May Reverse Glioblastoma Drug Resistance

Medical Xpress reports that scientists identified an experimental approach using BA-101 to restore the effectiveness of temozolomide in glioblastoma by blocking nitrosative stress. The findings suggest a potential strategy to address one of the disease’s toughest treatment obstacles.

Original headline

New experimental approach may help overcome drug resistance in deadly brain cancer